SubQSA
A Single-arm, Open-label, Phase 2 Study Evaluating Subcutaneous Administration of Isatuximab, Administered by an On Body Delivery System, in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)
Near Add Your Location
Sorting 39 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
- Show Principal Investigator
Memorial Sloan Kettering Monmouth
Middletown, NJ
- Accepting patients
- Show Principal Investigator
- Accepting patients
Tennessee Oncology - Hayes
Nashville, TN
- Accepting patients
Roper Hospital
Charleston, SC
- Accepting patients
- Accepting patients
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack Meridian Health
Hackensack, NJ
- Accepting patients
Mayo Clinic (Arizona)
Phoenix, AZ
- Accepting patients
SSM Health Cancer Care
Madison, WI
- Accepting patients
Oncology Hematology Care Inc. (Kenwood)
Cincinnati, OH
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.